The US Food and Drug Administration has approved a libido-enhancing drug for women dubbed the "female Viagra" or "Pink Viagra". Flibanserin, a drug produced by Sprout Pharmaceuticals and marketed as Addyi, recently passed an FDA advisory committee meeting. It has been criticised as having only marginal benefits and rejected by the FDA twice before.
Serving news stories on a digital plate.